(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 32.41% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.5%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.57%.
Gevo's revenue in 2025 is $80,187,000.On average, 2 Wall Street analysts forecast GEVO's revenue for 2025 to be $37,528,588,900, with the lowest GEVO revenue forecast at $35,959,053,251, and the highest GEVO revenue forecast at $39,098,124,549. On average, 2 Wall Street analysts forecast GEVO's revenue for 2026 to be $42,237,195,846, with the lowest GEVO revenue forecast at $39,414,933,747, and the highest GEVO revenue forecast at $45,059,457,945.
In 2027, GEVO is forecast to generate $45,019,554,496 in revenue, with the lowest revenue forecast at $41,712,405,036 and the highest revenue forecast at $48,326,703,956.